David Bodkin
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 4
- Oncology 9
- CAR-T cell therapy research 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Ronald Levy (4 shared papers)Ivor Royston (4 shared papers)James A. Neidhart (4 shared papers)Nalini Janakiraman (3 shared papers)Russell J. Schilder (2 shared papers)B.K. Dallaire (2 shared papers)Thomas A. Davis (2 shared papers)David G. Maloney (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (2 papers)Journal of Thoracic Oncology (2 papers)Lung Cancer (2 papers)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- United StatesCanadaHungary
In The Last Decade
David Bodkin
29 papers receiving 3.0k citations
David Bodkin's Hit Papers
Peers
Comparison fields: 5 of 99
- Genetics 583
- Pathology and Forensic Medicine 955
- Oncology 1.0k
- Radiology, Nuclear Medicine and Imaging 667
- Immunology and Allergy 169
Countries citing papers authored by David Bodkin
This map shows the geographic impact of David Bodkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bodkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bodkin more than expected).
Fields of papers citing papers by David Bodkin
This network shows the impact of papers produced by David Bodkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bodkin. The network helps show where David Bodkin may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bodkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma Hit paper breakdown → | 1997 | 1356 |
| 2 | IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. Hit paper breakdown → | 1997 | 529 |
| 3 | Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. | 2000 | 308 |
| 4 | 2009 | 194 | |
| 5 | 2007 | 160 | |
| 6 | 1997 | 116 | |
| 7 | 2006 | 85 | |
| 8 | 2011 | 58 | |
| 9 | 2009 | 51 | |
| 10 | 2008 | 36 | |
| 11 | 2005 | 28 | |
| 12 | 2006 | 28 | |
| 13 | 2012 | 26 | |
| 14 | 2005 | 23 | |
| 15 | 2011 | 20 | |
| 16 | 2006 | 17 | |
| 17 | 2010 | 17 | |
| 18 | 2020 | 16 | |
| 19 | 2007 | 14 | |
| 20 | 2003 | 13 |
About David Bodkin
David Bodkin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Aerospace Engineering, Radiology, Nuclear Medicine and Imaging and Computational Mechanics, having authored 29 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Aerospace and Aviation Technology (5 papers), Computational Fluid Dynamics and Aerodynamics (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (583 citations), Pathology and Forensic Medicine (955 citations), Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (667 citations) and Immunology and Allergy (169 citations). David Bodkin has collaborated with scholars based in United States, Canada and Hungary. Frequent co-authors include Ronald Levy, Ivor Royston, James A. Neidhart, Nalini Janakiraman, Russell J. Schilder, B.K. Dallaire, Thomas A. Davis, David G. Maloney, Antonio J Grillo-López and Kenneth A. Foon. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Thoracic Oncology, Lung Cancer and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.